| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |